Status epilepticus (SE) triggers neuronal death, reactive gliosis and remodeling of synaptic circuitry, thus leading to profound pathological alterations in CNS physiology. These processes are, in part, regulated by the rapid upregulation of both cytotoxic and cytoprotective genes. One pathway that may couple SE to transcriptionally dependent alterations in CNS physiology is the CREB (cAMP response elementbinding protein)/CRE (cAMP response element) cascade. Here, we utilized the pilocarpine model of SE on a mouse strain transgenic for a CRE-reporter construct (β-galactosidase) to begin to characterize how seizure activity regulates the activation state of the CREB/CRE pathway in both glia and neurons of the hippocampus. SE triggered a rapid (4-8 h post-SE) but transient increase in CRE-mediated gene expression in the neuronal sublayers. In contrast to neurons, SE induced a lasting increase (up to 20 days) in CRE-mediated transcription in both reactive astrocytes and microglia. CRE-mediated gene expression correlated with expression of the pro-inflammatory enzyme cyclooxygenase-2 (COX-2). To examine the role of CREB in SE-induced COX-2 expression, we generated a transgenic mouse strain that expresses A-CREB, a potent repressor of CREB-dependent transcription. In these animals, the capacity of SE to stimulate COX-2 expression was markedly attenuated, indicating that CREB is a key intermediate in SE-induced COX-2 expression. Collectively these data show that SE triggers two waves of CREB-mediated gene expression, a transient wave in neurons and a long-lasting wave in reactive glial cells, and that CREB couples SE to COX-2 expression.
Introduction
Seizures are the result of hypersynchronous electrical activity in the brain. A brain region particularly sensitive to the deleterious effects of status epilepticus (SE) is the hippocampal formation, a structure that is essential for advanced cognitive functions such as learning and memory. Individuals suffering from temporal lobe epilepsy often display pronounced cognitive deficits that dramatically diminish their quality of life (Reviewed by Jokeit and Ebner, 2002; Stefan and Pauli, 2002) . A well-established constellation of pathological changes resulting from SE has been characterized in the hippocampus, including neuronal death, reactive gliosis, remodeling of synaptic circuitry and a marked increase in neurogenesis (reviewed by Morimoto et al., 2004; Parent and Lowenstein, 2002; Jankowsky and Patterson, 2001 ). These profound alterations in the hippocampus follow a stereotypical pattern, from the acute loss of neurons in the CA1 and CA3 subfields, to the reorganization of the mossy fiber collaterals that occurs several weeks after SE.
Many of the SE-induced alterations in hippocampal physiology are mediated by a two-stage process. In the initial stage, the release of the excitatory amino acid neurotransmitter glutamate leads to rapid neuronal cell death (Olney et al., 1983; Ingvar et al., 1988; Covolan and Mello, 2000) , and in the second phase, glutamate, in combination with trophic factors and cytokines, drives a wave of transcriptional activity that likely confers both a neuroprotective response and contributes to seizure-induced brain pathology. Along these lines, seizure activity has been shown to stimulate the expression of brain derived neurotrophic factor (BDNF; Isackson et al., 1991; Ernfors et al., 1991) , which would function in a neuroprotective manner (Young et al., 1999; Revuelta et al., 2001) , cyclooxygenase-2 (COX-2; Tu and Bazan, 2003; Kawaguchi et al., 2005) which may contribute to neuronal cell death (Dore et al., 2003; Rockwell et al., 2004; Kawaguchi et al., 2005) , and tissue plasminogen activator (tPA; Qian et al., 1993; Tsirka et al., 1995) , which has been shown to elicit neuronal structural changes (Wu et al., 2000) . Because of the role gene expression plays in SEinduced alterations in hippocampal physiology, there is a clear need to begin to identify the cellular signaling and inducible transcription events that are activated by synchronous synaptic discharges. Within this context, it is of interest to note studies showing a persistent activation of the transcription factor CREB (cAMP response element binding protein) and expression of CREB-regulated immediate early genes such as EGR-1 and c-fos in epileptic foci (Rakhade et al., 2005; Gass et al., 1997; Kiessling and Gass, 1993; Simonato et al., 1991) . These findings suggest a role for CREB in the genetic response to seizure activity.
